Stock SCPS SCOPUS BIOPHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Scopus BioPharma Inc.

Equities

SCPS

US8091711015

Market Closed - OTC Markets
Other stock markets
 16:18:00 26/04/2024 BST 		5-day change 1st Jan Change
0.0011 USD 0.00% Intraday chart for Scopus BioPharma Inc. -31.25% -97.45%
2023 Scopus BioPharma Inc. Presents DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma CI
2023 Scopus BioPharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer
GL
Scopus BioPharma Inc. Presents DUET-102 in Combination with PD-1 Blockade Demonstrates Significant Anti-Tumor Activity in Models of Malignant Glioma
CI
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
GL
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer
AQ
Scopus BioPharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Scopus BioPharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Scopus BioPharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Scopus BioPharma Inc. Auditor Raises 'Going Concern' Doubt
CI
Scopus BioPharma Inc.(NasdaqCM:SCPS) dropped from S&P TMI Index
CI
SCOPUS BIOPHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
Scopus BioPharma : Failure to Satisfy Listing Rule - Form 8-K
PU
Scopus BioPharma Inc.(NasdaqGM:SCPS) dropped from NASDAQ Composite Index
CI
Weaker-Than-Expected Retail Sales, Hawkish Fed Send US Stock Futures Sharply Lower
MT
Federal Reserve's Still-Hawkish Stance Appears to Disappoint Investors; US Futures Move Lower
MT
Top Premarket Gainers
MT
SCOPUS BIOPHARMA INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
SCOPUS BIOPHARMA INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
Scopus BioPharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer
GL
Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Announces Key Scientific Data to be Presented at the 37th Annual Meeting and Exposition of the Society for Immunotherapy of Cancer
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SCPS Stock
  4. News Scopus BioPharma Inc.